Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients

Digestive and Liver Disease

Volumn 45, Issue 8, 2013, Pages 677-682

  Huang, Hai jun ^a,b   Zhang, An ye ^a   Cao, Hong cui ^a   Lu, Hai feng ^a   Wang, Bao hong ^a   Xie, Qing ^a   Xu, Wei ^a   Li, Lan Juan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Faecal water extracts; Liver cirrhosis; Metabolomics; UPLC Q TOF MS

Indexed keywords

ACYLCARNITINE; AROMATIC AMINO ACID; BILE ACID; BILE PIGMENT; FATTY ACID; LYSOPHOSPHATIDYLCHOLINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FECES ANALYSIS; FEMALE; HUMAN; LIVER CIRRHOSIS; MALABSORPTION; MALE; METABOLITE; METABOLOMICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

FAECAL WATER EXTRACTS; LIVER CIRRHOSIS; METABOLOMICS; UPLC/Q-TOF MS;

ADULT; AMINO ACIDS, AROMATIC; BILE ACIDS AND SALTS; BILE PIGMENTS; CARNITINE; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; FATTY ACIDS; FECES; FEMALE; HUMANS; LIPID METABOLISM; LIVER CIRRHOSIS; LYSOPHOSPHATIDYLCHOLINES; MALABSORPTION SYNDROMES; MALE; MASS SPECTROMETRY; METABOLOME; MIDDLE AGED;

EID: 84881558436     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.01.001     Document Type: Article

References (39)

1. Schuppan D., Afdhal N.H. Liver cirrhosis. Lancet 2008, 8(371(9615)):838-851.
2. Befeler A.S., Di Bisceglie A.M. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002, 122(6):1609-1619.
3. Want E.J., Nordstrom A., Morita H., et al. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. Journal of Proteome Research 2007, 6:459-468.
4. Marchesi J.R., Holmes E., Khan F., et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. Journal of Proteome Research 2007, 6:546-551.
5. Yu K., Sheng G., Sheng J., et al. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. Journal of Proteome Research 2007, 6:2413-2419.
6. Li M., Wang B., Zhang M., et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:2117-2122.
7. Dumas M.E., Barton R.H., Toye A., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:12511-12516.
8. Nicholson J.K., Holmes E., Wilson I.D. Gut microorganisms, mammalian metabolism and personalized health care. Nature Reviews Microbiology 2005, 3:431-438.
9. Yang J., Zhao X., Liu X., et al. High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B. Journal of Proteome Research 2006, 5:554-561.
10. Yin P., Wan D., Zhao C., et al. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Molecular BioSystems 2009, 5:868-876.
11. Smith C.A., O'Maille G., Want E.J., et al. METLIN: a metabolite mass spectral database. Therapeutic Drug Monitoring 2005, 27:747-751.
12. Wishart D.S., Tzur D., Knox C., et al. HMDB: the human metabolome database. Nucleic Acids Research 2007, 35:D521-D526.
13. Kanehisa M., Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Research 2000, 28:27-30.
14. Fukiya S., Arata M., Kawashima H., et al. Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by bacteroides intestinalis AM-1 isolated from human feces. FEMS Microbiology Letters 2009, 293:263-270.
15. Matoba N., Une M., Hoshita T. Identification of unconjugated bile acids in human bile. Journal of Lipid Research 1986, 27:1154-1162.
16. Hamilton J.P., Xie G., Raufman J.P., et al. Human cecal bile acids: concentration and spectrum. American Journal of Physiology - Gastrointestinal and Liver Physiology 2007, 293:G256-G263.
17. Perwaiz S., Tuchweber B., Mignault D., et al. Determination of bile acids in biological fluids by liquid chromatography-electrospray tandem mass spectrometry. Journal of Lipid Research 2001, 42:114-119.
18. Lorenzo-Zuniga V., Bartoli R., Planas R., et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology 2003, 37:551-557.
19. Lanspa S.J., Chan A.T., Bell J.S., et al. Pathogenesis of steatorrhea in primary biliary cirrhosis. Hepatology 1985, 5:837-842.
20. Raedsch R., Stiehl A., Gundert-Remy U., et al. Hepatic secretion of bilirubin and biliary lipids in patients with alcoholic cirrhosis of the liver. Digestion 1983, 26:80-88.
21. Aldini R., Montagnani M., Roda A., et al. Intestinal Absorption of bile acids in rabbit: different transport rates in jejunum and ileum. Gastroenterology 1996, 110(2):459-468.
22. Aldini R., Roda A., Montagnani M., et al. Relationship between structure and intestinal absorption of bile acids with a steroid or side chain modification. Steroids 1996, 61:590-597.
23. Fahmy K., Gray C.H., Nicholson D.C. The reduction of bile pigments by faecal and intestinal bacteria. Biochimica et Biophysica Acta 1972, 264:85-97.
24. Ohkubo A. Bilirubin metabolism in liver cirrhosis. Japanese Journal of Clinical Medicine 1994, 52:138-144.
25. Vitek L., Zelenka J., Zadinova M., et al. The impact of intestinal microflora on serum bilirubin levels. Journal of Hepatology 2005, 42:238-243.
26. Sarin S.K., Lal K., Sachdeva G., et al. Biliary lipid composition in patients with non-cirrhotic portal fibrosis - a comparison with compensated cirrhosis of the liver. Liver 1987, 7:38-42.
27. Chen A.H., Innis S.M., Davidson A.G., et al. Phosphatidylcholine and lysophosphatidylcholine excretion is increased in children with cystic fibrosis and is associated with plasma homocysteine, S-adenosylhomocysteine, and S-adenosylmethionine. American Journal of Clinical Nutrition 2005, 81:686-691.
28. Sakai T. Pancreatic exocrine function in patients with chronic liver disease. Kurume Medical Journal 1998, 45(2):181-185.
29. Benno Y., Sawada K., Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiology and Immunology 1984, 28:975-986.
30. Benno Y., Endo K., Mizutani T., et al. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Applied and Environment Microbiology 1989, 55:1100-1105.
31. Tessari P., Barazzoni R., Kiwanuka E., et al. Impairment of albumin and whole body postprandial protein synthesis in compensated liver cirrhosis. American Journal of Physiology - Endocrinology and Metabolism 2002, 282:E304-E311.
32. O'Keefe S.J., Abraham R., El-Zayadi A., et al. Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and reduced hepatic oxidation capacity. Gastroenterology 1981, 81:1017-1024.
33. Tessari P., Inchiostro S., Barazzoni R., et al. Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis. American Journal of Physiology 1994, 267:E140-E149.
34. Wikoff W.R., Anfora A.T., Liu J., et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:3698-3703.
35. Leat W.M. Nutritional deficiencies and fatty acid metabolism. Proceedings of the Nutrition Society 1983, 42:333-342.
36. Rashed M.S., Ozand P.T., Bennett M.J.B, et al. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile. Clinical Chemistry 1995, 41:1109-1114.
37. Fuda F., Narayan S.B., Squires R.H., et al. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects. Clinica Chimica Acta 2006, 367:185-188.
38. Krahenbuhl S., Reichen J. Carnitine metabolism in patients with chronic liver disease. Hepatology 1997, 25:148-153.
39. Kleber H.P. Bacterial carnitine metabolism. FEMS Microbiology Letters 1997, 147:1-9.